Navigating the New Frontier in Therapy Care for Individuals with Spinal Muscular Atrophy (SMA): Part I: Overview of SMA, Medical Advancements, Changing Outcomes & Phenotypes

DESCRIPTION
This course will provide a brief overview to the pathophysiology of SMA, address the FDA approved and currently available pharmacologic treatments, and discuss the influence these treatments have on changing outcomes and phenotypes and impact these may have for in rehabilitation.

LEARNER OUTCOMES
Upon completion of this course, participants will be able to: 

1. Discuss the current available treatments in Spinal Muscular Atrophy and potential impact on pathophysiology of SMA
2. Recognizes the changing clinical presentation with treatment
3. Describes general rehabilitation considerations with changes in treatment

INSTRUCTORS
Laurey Brown, PT, DPT, PCS; Katie Hoffman, PT, DPT; Kristin J. Krosschell, PT, DPT, MA, PCS & Christa Weigel PT, DPT, PCS

AUDIENCE
Occupational Therapists, Occupational Therapy Assistants, Physical Therapists, Physical Therapist Assistants

SUCCESSFUL COMPLETION
Participants will watch the on-demand recording in its entirety and complete an assessment and feedback module in the Academy Learning Portal. You will have three months from the date of purchase to complete and review the course material. You will receive a reminder email two weeks before the expiration date. 

CONTINUING EDUCATION CREDITS

Occupational Therapy

The Shirley Ryan AbilityLab is an AOTA Approved Provider of professional development. Course approval ID# 02753. This distance learning – independent and interactive webinar is offered at .10 CEUs [intermediate, OT service delivery/ Foundational Knowledge]. AOTA does not endorse specific course content, products, or clinical procedures.

Physical Therapy
The Illinois Physical Therapy Board has approved this course for 1.0 Contact Hours.  Approval #216-000069

Shirley Ryan AbilityLab is recognized by California and the New York State Education Department's State Board for Physical Therapy as an approved provider of physical therapy and physical therapist assistant continuing education for 1.5 Contact Hours on 9/30/2024.

Many states accept continuing education contact hours recognized in other states, enabling professionals to use these hours to meet their licensing or certification requirements. Please consult your state regulations to see if this meets CEU requirements for your license.

DISCLOSURES
Course Directors and Planning Committee Members:
Julie Lenkiewicz, MS, CCC-SLP Has nothing to disclose.
Melissa Kolski, PT, OCS, Dip MDT Has nothing to disclose.
Leslie Marriott, OTR/L Has nothing to disclose.
Selah Bustamante, MSN, RN, CRRN Has nothing to disclose.
Melissa Legreid, MSN, RN, CRRN, NPD-BC Has nothing to disclose.
Speakers, Moderators and Panelists:
Laurey Brown - Receives consulting fees and speaking fees from Biogen; receives speaking fees from Sarepta
Katie Hoffman - Receives an honorarium for serving on the Roche/Genentech Advisory Board
Kristin J. Krosschell - Receives consulting fees from Biogen; receives honorarium and consulting fees from Cure SMA and serves on their Medical Advisory Committee; receives consulting fees from Aspa Therapeutics; receives an honorarium from Roche-Genentech for serving on Advisory Board. Serves as Chair of Rehabilitation Committee for Cure SMA Medical Advisory Council
Christa Weigel - Has nothing to disclose.

ACADEMY POLICIES
For a complete list of Academy policies and technology requirements, click here.